Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.38 |
| ▸ | SLC34A1 | Q06495 | 5/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.35 |
| ▸ | IGF1R | P08069 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17200657 | 0.95 | HSD11B1 (0.40) | HSD11B1SLC34A1P2RX7IGF1RCYP3A4 | |
| SCHEMBL17164758 | 0.94 | HSD11B1 (0.40) | HSD11B1SLC34A1P2RX7IGF1RCRHR1 | |
| SCHEMBL168744 | 0.93 | SLC34A1 (0.41) | HSD11B1SLC34A1P2RX7IGF1RCYP3A4 | |
| SCHEMBL170613 | 0.92 | HSD11B1 (0.39) | HSD11B1SLC34A1P2RX7IGF1RCYP3A4 | |
| SCHEMBL17200645 | 0.90 | MAPT (0.36) | HSD11B1SLC34A1P2RX7 | |
| SCHEMBL17200658 | 0.90 | HSD11B1 (0.36) | HSD11B1SLC34A1P2RX7IGF1RCYP3A4 | |
| SCHEMBL29368805 | 0.90 | HSD11B1 (0.40) | HSD11B1SLC34A1P2RX7IGF1RCYP3A4 | |
| SCHEMBL173677 | 0.90 | HSD11B1 (0.40) | HSD11B1SLC34A1P2RX7IGF1RCYP3A4 | |
| SCHEMBL173410 | 0.90 | SLC34A1 (0.41) | HSD11B1SLC34A1P2RX7IGF1RCYP3A4 | |
| SCHEMBL173545 | 0.89 | HSD11B1 (0.42) | HSD11B1SLC34A1P2RX7IGF1RPTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9464056-B2 | Fungicidal 4-methylanilino pyrazoles | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-10-11 | — | — | US | claimed |
| EP-2864293-B1 | FUNGICIDAL 4-METHYLANILINO PYRAZOLES | DU PONT (US) | 2016-04-27 | — | — | EP | claimed |
| US-20150307456-A1 | FUNGICIDAL 4-METHYLANILINO PYRAZOLES | FMC CORPORATION | 2015-10-29 | — | — | US | claimed |
| US-9888688-B2 | Tetrazolinone compounds and applications thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9888688-B2 | Tetrazolinone compounds and applications thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9781933-B2 | Tetrazolinone compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-10 | — | — | US | disclosed |
| US-9781933-B2 | Tetrazolinone compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-10 | — | — | US | disclosed |
| US-9464056-B2 | Fungicidal 4-methylanilino pyrazoles | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-10-11 | — | — | US | disclosed |
| US-20160174558-A1 | TETRAZOLINONE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-23 | — | — | US | disclosed |
| US-20160174558-A1 | TETRAZOLINONE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-23 | — | — | US | disclosed |
| US-20160150787-A1 | TETRAZOLINONE COMPOUNDS AND APPLICATIONS THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20160150787-A1 | TETRAZOLINONE COMPOUNDS AND APPLICATIONS THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-3020715-A1 | TETRAZOLINONE COMPOUND AND USE THEREOF | Sumitomo Chemical Company Limited (JP) | 2016-05-18 | — | — | EP | disclosed |
| EP-2864293-B1 | FUNGICIDAL 4-METHYLANILINO PYRAZOLES | DU PONT (US) | 2016-04-27 | — | — | EP | disclosed |
| US-20150307456-A1 | FUNGICIDAL 4-METHYLANILINO PYRAZOLES | FMC CORPORATION | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160174558-A1 | TETRAZOLINONE COMPOUND AND USE THEREOF | MT-CO1, KCNA5, MT-CO2 | HSD11B1 2693/4885SLC34A1 2825/4885P2RX7 477/4885 |
| US-20160150787-A1 | TETRAZOLINONE COMPOUNDS AND APPLICATIONS THEREOF | SOD1, UQCRB, MT-CO1 | HSD11B1 1971/4885SLC34A1 4174/4885P2RX7 814/4885 |
| US-20150307456-A1 | FUNGICIDAL 4-METHYLANILINO PYRAZOLES | CYP2F1, CYP1B1, CYP4B1 | HSD11B1 171/4885SLC34A1 1978/4885P2RX7 1520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.